Resources » WFH Treatment Guidelines: Practical Application in the Middle East | July 30, 2021

Year: 2021

Language: English

This resource is also available in: Arabic French

Author(s): World Federation of Hemophilia

Format: Video

WFH Treatment Guidelines: Practical Application in the Middle East | July 30, 2021


Listen to this 90-minute webinar presented on July 30, 2021, on the WFH Guidelines for the Management of Hemophilia, 3rd edition and their practical application in the Middle East.

The session was moderated by Alok Srivastava (Professor in the Department of Haematology, and Head of the Centre for Stem Cell Research at the Christian Medical College, Vellore and Content Lead, WFH Guidelines for the Management of Hemophilia).

Speakers, including Emna Gouider (Department Head, Aziza Othmana Hospital), Abdulhakim Al-Rawas (Senior Consultant in the Pediatric Hematology/Oncology Unit, Child Health Department in Sultan Qaboos University Hospital), Magdy El Ekiaby (Head of BTC & HTC, Chabrawishi Hospital), and Cesar Haddad (Lebanese Association for Hemophilia), presented examples of regional cases followed by expert discussions and a Q&A period.

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.